Functional and clinical aspects of the myelomonocyte protein calprotectin.
作者信息
Johne B, Fagerhol M K, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen C F, Dale I
机构信息
Nycomed Pharma AS, Oslo, Norway.
出版信息
Mol Pathol. 1997 Jun;50(3):113-23. doi: 10.1136/mp.50.3.113.
Abstract
摘要
相似文献
1
Functional and clinical aspects of the myelomonocyte protein calprotectin.
Mol Pathol. 1997 Jun;50(3):113-23. doi: 10.1136/mp.50.3.113.
2
The mechanism of calprotectin's candidastatic activity appears to involve zinc chelation.
Biochem Soc Trans. 1996 May;24(2):309S. doi: 10.1042/bst024309s.
3
The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces.
Adv Exp Med Biol. 1995;371A:201-6. doi: 10.1007/978-1-4615-1941-6_41.
4
His-X-X-X-His motif in S100 protein, calprotectin: relation to microbiostatic activity.
J Leukoc Biol. 1996 Nov;60(5):674. doi: 10.1002/jlb.60.5.674.
5
Elevated plasma levels of L1L and L1H in CF patients.
Biochem Soc Trans. 1996 May;24(2):310S. doi: 10.1042/bst024310s.
6
Calprotectin as a marker of inflammation in cystic fibrosis.
Arch Dis Child. 1996 Feb;74(2):136-9. doi: 10.1136/adc.74.2.136.
7
Autoantibodies to calprotectin are not found in patients with systemic lupus erythematosus or other inflammatory rheumatic diseases.
Lupus. 1995 Dec;4(6):498. doi: 10.1177/096120339500400616.
8
Differential expression of leucocyte protein L1 (calprotectin) by monocytes and intestinal macrophages.
Adv Exp Med Biol. 1995;371A:207-10. doi: 10.1007/978-1-4615-1941-6_42.
9
Microbiostatic activity of human plasma and its relation to zinc and iron availability.
Biochem Soc Trans. 1996 May;24(2):311S. doi: 10.1042/bst024311s.
10
Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14).
J Infect Dis. 2000 Oct;182(4):1272-5. doi: 10.1086/315810. Epub 2000 Sep 5.
引用本文的文献
1
Unveiling the Diagnostic Significance of Calprotectin in Serous Ovarian Carcinoma.
Life (Basel). 2025 Jul 8;15(7):1080. doi: 10.3390/life15071080.
2
Integrated multi-omics of feces, plasma and urine can describe and differentiate pediatric active Crohn's Disease from remission.
Commun Med (Lond). 2025 Jul 8;5(1):281. doi: 10.1038/s43856-025-00984-7.
3
Predictive accuracy of fecal calprotectin in assessing clinical activity and disease severity in patients with Ulcerative Colitis and Crohn's disease.
BMC Gastroenterol. 2025 Jun 4;25(1):429. doi: 10.1186/s12876-025-04035-2.
4
Calprotectin-mediated survival of in coculture with occurs without nutrient metal sequestration.
mBio. 2025 May 14;16(5):e0384624. doi: 10.1128/mbio.03846-24. Epub 2025 Mar 28.
5
Association of maternal calprotectin plasma levels with abruption placenta.
BMC Pregnancy Childbirth. 2025 Mar 7;25(1):249. doi: 10.1186/s12884-025-07356-y.
6
Can Faecal Zonulin and Calprotectin Levels Be Used in the Diagnosis and Follow-Up in Infants with Milk Protein-Induced Allergic Proctocolitis?
Nutrients. 2024 Sep 2;16(17):2949. doi: 10.3390/nu16172949.
7
Saffron as a Promising Therapy for Inflammatory Bowel Disease.
Nutrients. 2024 Jul 20;16(14):2353. doi: 10.3390/nu16142353.
8
Development of Luminescent Biosensors for Calprotectin.
ACS Chem Biol. 2024 Jun 21;19(6):1250-1259. doi: 10.1021/acschembio.4c00265. Epub 2024 Jun 6.
9
A critical role for iron and zinc homeostatic systems in the evolutionary adaptation of to metal restriction.
Microb Genom. 2023 Dec;9(12). doi: 10.1099/mgen.0.001153.
10
Serum calprotectin as a marker of neonatal sepsis: a hospital-based cross-sectional diagnostic study.
F1000Res. 2023 Nov 9;12:626. doi: 10.12688/f1000research.132099.1. eCollection 2023.
本文引用的文献
1
Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein).
Clin Mol Pathol. 1995 Oct;48(5):M278-84. doi: 10.1136/mp.48.5.m278.
2
Tissue fractionation studies. 4. Comparative study of the binding of acid phosphatase, beta-glucuronidase and cathepsin by rat-liver particles.
Biochem J. 1955 Mar;59(3):433-8. doi: 10.1042/bj0590433.
3
Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein.
Digestion. 1997;58(2):176-80. doi: 10.1159/000201441.
4
Expression of the L1 antigen (calprotectin) by tissue macrophages reflects recent recruitment from peripheral blood rather than upregulation of local synthesis: implications for rejection diagnosis in formalin-fixed kidney specimens.
J Pathol. 1996 Oct;180(2):194-9. doi: 10.1002/(SICI)1096-9896(199610)180:2<194::AID-PATH628>3.0.CO;2-P.
5
Enzyme-linked immunosorbent assay for human MRP-8/MRP-14 proteins and their quantitation in plasma of hematological patients.
Immunol Lett. 1996 Jan;49(1-2):7-13. doi: 10.1016/0165-2478(95)02472-7.
6
Inhibition of Candida albicans growth by calprotectin in the absence of direct contact with the organisms.
J Infect Dis. 1996 Dec;174(6):1369-72. doi: 10.1093/infdis/174.6.1369.
7
The monoclonal antibody Mac 387 recognizes three S100 proteins in human neutrophils.
Immunol Cell Biol. 1996 Feb;74(1):105-7. doi: 10.1038/icb.1996.14.
8
Phosphorylation of myeloid-related proteins MRP-14 and MRP-8 during human neutrophil activation.
Eur J Biochem. 1996 Oct 1;241(1):265-71. doi: 10.1111/j.1432-1033.1996.0265t.x.
9
Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin.
Scand J Gastroenterol. 1996 Oct;31(10):1001-5. doi: 10.3109/00365529609003120.
10
The mechanism of calprotectin's candidastatic activity appears to involve zinc chelation.
Biochem Soc Trans. 1996 May;24(2):309S. doi: 10.1042/bst024309s.
Zotero 插件